Phase II study of the HSP90-inhibitor BIIB021 in gastrointestinal stromal tumors

Lignende værker

• The heat shock protein 90 inhibitor BIIB021 suppresses the growth of T and natural killer cell lymphomas
  af: Suzuki, Michio, et al.
  Udgivet: (2015)
• The HSP90 Inhibitor, AT13387, Is Effective against Imatinib-Sensitive and -Resistant Gastrointestinal Stromal Tumor Models
  af: Smyth, Tomoko, et al.
  Udgivet: (2012)
• Hsp90 inhibitor BIIB021 enhances triptolide-induced apoptosis of human T-cell acute lymphoblastic leukemia cells in vitro mainly by disrupting p53-MDM2 balance
  af: Li, Min, et al.
  Udgivet: (2013)
• Multicenter Phase II Trial of Sunitinib in the Treatment of Nongastrointestinal Stromal Tumor Sarcomas
  af: George, Suzanne, et al.
  Udgivet: (2009)
• BIIB021, an Hsp90 inhibitor, effectively kills a myelodysplastic syndrome cell line via the activation of caspases and inhibition of PI3K/Akt and NF-κB pathway proteins
  af: LIN, SHENGYUN, et al.
  Udgivet: (2014)